title: A practice-based research network focused on comparative effectiveness research in type 2 diabetes management.
abstract: OBJECTIVE
  To establish a real-world research platform focused on comparative effectiveness research and health care decision making in diabetes care in order to obtain a detailed understanding of individualized patient management in primary care.
  
  
  METHODS
  Diabetes FORWARD (Foundation of Real-World Assessment and Research in Diabetes) is a North American research platform being organized to conduct longitudinal, noninterventional investigations of an anticipated 10,000 patients with type 2 diabetes mellitus (T2DM). Recruitment will be stratified to reflect typical (primarily primary care) clinical T2DM populations. Streamlined data collection relying on electronic medical records (retrospective) and periodic surveys (prospective) will reduce the burden of study participation and, therefore, enhance enrollment by busy primary care and endocrinology practices. Physician data will include baseline demographic and practice information. Patient data will include demographics, T2DM characteristics and treatment, resource utilization information, and patient-reported outcomes. Responses can be tracked within the observation window in near-real time, allowing immediate, noninterventional reaction at the point of nonresponse.
  
  
  OBJECTIVE
  Diabetes FORWARD is expected to provide important real-world data describing how actual clinical T2DM management differs across sites, settings, and clinicians, and its impact on glycemic control, treatment adherence and persistence, and clinical outcomes. These data will also help to identify the effect of diabetes management on the onset and progression of retinopathy, neuropathy, nephropathy, and cardiovascular disease at 6-month intervals.
  
  
  CONCLUSIONS
  To our knowledge, Diabetes FORWARD is the first diabetes-focused, practice-based research network in the United States and Canada. The current study will provide robust data that should reflect typical management of T2DM in clinical practice in North America.
authors.affiliation: The Frist Clinic, Nashville, TN 37203, USA. john.anderson1@hcahealthcare.com
authors.forename: John E
authors.initials: JE
authors.lastname: Anderson
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Rhinehart
authors.forename: Timothy S
authors.initials: TS
authors.lastname: Reid
authors.forename: Robert M
authors.initials: RM
authors.lastname: Cuddihy
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Vlajnic
authors.forename: Mehul R
authors.initials: MR
authors.lastname: Dalal
authors.forename: Eric
authors.initials: E
authors.lastname: Gemmen
authors.forename: Bryan
authors.initials: B
authors.lastname: Johnstone
authors.forename: Babak
authors.initials: B
authors.lastname: Abbaszadeh
authors.forename: Josh
authors.initials: J
authors.lastname: Reed
authors.forename: Jennifer
authors.initials: J
authors.lastname: Sheller
authors.forename: John
authors.initials: J
authors.lastname: Stewart
authors.forename: Essy
authors.initials: E
authors.lastname: Mozaffari
mesh_terms: D000328:Adult; D057186:Comparative Effectiveness Research / Q000379:methods* / Q000458:organization & administration; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy*; D006801:Humans; D008137:Longitudinal Studies; D018579:Patient Selection; D011320:Primary Health Care / Q000379:methods / Q000706:statistics & numerical data